← Leaderboards
Jianjun Zhao
Cleveland Clinic Lerner Com-Cwru
$4,763,851
Attributed
$5,848,093
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,848,093 · 4
By mechanism
R01$4,848,640 · 2
R00$746,997 · 1
K99$252,456 · 1
Top collaborators
- Jennifer S Yu4 shared
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Shideng Bao$9,894,339
- Jennifer S Yu$6,177,422
- Jeongwu Lee$5,183,445
- Anita Borton Hjelmeland$6,940,856
- Tyler Eugene Miller$823,129
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProteinsMalignant NeoplasmsPathway InteractionsTumorMouse ModelIn VivoGenetic TranscriptionCancer PatientTherapeutic TargetEventTransgenic MicePathogenesisResponseChemotherapySamplingAntisense OligonucleotidesClinical TrialsTransgenic OrganismsDoseKnock-DownMaintenanceCell NucleusMalignant - Descriptor
Grant awards (15)
lncRNA regulation of glioblastoma progression and therapeutic resistance$547,221
R01 · FY2025 · NS
New mouse model of cisplatin-induced AKI and development of prevention therapy$472,634
R01 · FY2025 · CA · contact PI
lncRNA regulation of glioblastoma progression and therapeutic resistance$530,805
R01 · FY2024 · NS
New mouse model of cisplatin-induced AKI and development of prevention therapy$449,002
R01 · FY2024 · CA · contact PI
lncRNA regulation of glioblastoma progression and therapeutic resistance$547,221
R01 · FY2023 · NS
New mouse model of cisplatin-induced AKI and development of prevention therapy$529,333
R01 · FY2023 · CA · contact PI
Visium spatial transcriptome analysis add on to the current proposed scRNA seq analysis$136,600
R01 · FY2023 · CA · contact PI
lncRNA regulation of glioblastoma progression and therapeutic resistance$543,237
R01 · FY2022 · NS
New mouse model of cisplatin-induced AKI and development of prevention therapy$531,973
R01 · FY2022 · CA · contact PI
New mouse model of cisplatin-induced AKI and development of prevention therapy$560,614
R01 · FY2021 · CA · contact PI
Elucidating the role of microRNAs in the initiation of multiple myeloma$248,999
R00 · FY2017 · CA · contact PI
Elucidating the role of microRNAs in the initiation of multiple myeloma$248,999
R00 · FY2016 · CA · contact PI
Elucidating the role of microRNAs in the initiation of multiple myeloma$248,999
R00 · FY2015 · CA · contact PI
Elucidating the role of microRNAs in the initiation of multiple myeloma$126,228
K99 · FY2014 · CA · contact PI
Elucidating the role of microRNAs in the initiation of multiple myeloma$126,228
K99 · FY2013 · CA · contact PI